- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 5.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.69M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 5.6M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$7.98M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$10.21M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $41.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.37M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $50.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $57.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $54.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $61.65M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.14M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.22M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.2M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.31M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $53.49M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $61.25M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $54.47M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $62.26M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.46 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.69 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.46 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.69 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.07M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.16M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.87M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $5.73M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$9.44M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.73M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$9.67M |
| Revenue | Q1 2026 · Mar 31, 2026 | $212K |
| Revenue | Q1 2026 · Mar 31, 2025 | $212K |